Who
Kyle Moran
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Wave Life Sciences.
In numbers
- Trades disclosed
- 43
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $4.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 16 Jun 2016
- Last trade
- 9 Feb 2026
- Last filed
- 11 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $48K3,588 at $13.45 | filing |
| 9 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $48K3,588 at $13.45 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —45,625 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —273,750 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —273,750 at $0.00 | filing |
| 5 Feb 2026filed 11 Feb 2026 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code A | —45,625 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $294K36,000 at $8.17 | filing |
| 9 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $72936 at $20.25 | filing |
| 9 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $524K50,000 at $10.48 | filing |
| 9 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $1.0M50,000 at $20.03 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life Sciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $170K60,000 at $2.83 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $792K60,000 at $13.20 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Code M | $314K100,000 at $3.14 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $750K50,000 at $15.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | WVE Wave Life SciencesBiotechnology | SEC FORM 4 Sold | $660K50,000 at $13.20 | filing |
News
Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026WVE · manilatimes.net · 20 Oct 2026Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026WVE · manilatimes.net · 19 Oct 2026WAVE Life Sciences (NASDAQ:WVE) and Alumis (NASDAQ:ALMS) Head to Head ComparisonWVE · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Kyle Moran; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.